Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug
Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA
Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
Macitentan tablets, 10 mg have an estimated market size of US $ 797 million for twelve months ending Dec 2021 according to IQVIA
Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout
Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
To be marketed by Strides Pharma Inc. in the US market
It has a total of 50 ANDA approvals from USFDA
Subscribe To Our Newsletter & Stay Updated